Shuo Feng1, Susan S Chiu2, Eunice L Y Chan2, Mike Y W Kwan3, Joshua S C Wong3, Chi-Wai Leung3, Yiu Chung Lau1, Sheena G Sullivan4, J S Malik Peiris1, Benjamin J Cowling5. 1. WHO Collaborating Centre for Infectious Disease Epidemiology and Control, School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, China. 2. Department of Paediatrics and Adolescent Medicine, Queen Mary Hospital and Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, China. 3. Department of Paediatrics and Adolescent Medicine, Princess Margaret Hospital, Hong Kong Special Administrative Region, China. 4. WHO Collaborating Center for Reference and Research on Influenza at the Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia; Department of Epidemiology, Fielding School of Public Health, University of California, Los Angeles, Los Angeles, CA, USA; Centre for Epidemiology and Biostatistics, School of Population and Global Health, University of Melbourne, Melbourne, VIC, Australia. 5. WHO Collaborating Centre for Infectious Disease Epidemiology and Control, School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, China. Electronic address: bcowling@hku.hk.
Abstract
BACKGROUND: The protection conferred by influenza vaccination is generally thought to last less than a year, necessitating annual revaccination. However, the speed with which influenza vaccine effectiveness might decline during a year is unknown, which is of particular importance for locations with year-round influenza activity. We aimed to assess how influenza vaccine effectiveness changes by time intervals between vaccination and admission to hospital, taking advantage of almost year-round circulation of influenza in Hong Kong. METHODS: In this test-negative case-control study, we analysed vaccine effectiveness in children (aged 6 months to 17 years) who were admitted to hospital in Hong Kong over 5 consecutive years (2012-17). We included those who were admitted to general wards in four public hospitals in Hong Kong with a fever (≥38°C) and any respiratory symptom, such as runny nose, cough, or sore throat. We used direct immunofluorescence assay and reverse transcription PCR to detect influenza virus infection, and recorded children's influenza immunisation history. We compared characteristics of positive cases and negative controls and examined how vaccine effectiveness changed by time between vaccination and admission to hospital with regression analyses. FINDINGS: Between Sept 1, 2012, and Aug 31, 2017, we enrolled 15 695 children hospitalised for respiratory infections, including 2500 (15·9%) who tested positive for influenza A or B and 13 195 (84·1%) who tested negative. 159 (6·4%) influenza-positive cases and 1445 (11·0%) influenza-negative cases had been vaccinated. Most vaccinations were done by December of each influenza vaccination season. Influenza-related admissions to hospital occurred year-round, with peaks in January through March in most years and a large summer peak in 2016; pooled vaccine effectiveness for children of all ages was 79% (95% CI 42-92) for September to December, 67% (57-74) for January to April, and 43% (25-57) for May to August. Vaccine effectiveness against influenza A or B was estimated as 79% (95% CI 64-88) within 0·5-2 months of vaccination, 60% (46-71) within >2-4 months, 57% (39-70) within >4-6 months, and 45% (22-61) within >6-9 months. In separate analyses by type and subtype, we estimated that vaccine effectiveness declined by 2-5 percentage points per month. INTERPRETATION: Influenza vaccine effectiveness decreased during the 9 months after vaccination in children in Hong Kong. Our findings confirm the importance of annual vaccination in children. Influenza vaccines that provide broader and longer-lasting protection are needed to provide year-round protection in regions with irregular influenza seasonality or lengthy periods of influenza activity. FUNDING: Health and Medical Research Fund, Hong Kong and the Research Grants Council, Hong Kong.
BACKGROUND: The protection conferred by influenza vaccination is generally thought to last less than a year, necessitating annual revaccination. However, the speed with which influenza vaccine effectiveness might decline during a year is unknown, which is of particular importance for locations with year-round influenza activity. We aimed to assess how influenza vaccine effectiveness changes by time intervals between vaccination and admission to hospital, taking advantage of almost year-round circulation of influenza in Hong Kong. METHODS: In this test-negative case-control study, we analysed vaccine effectiveness in children (aged 6 months to 17 years) who were admitted to hospital in Hong Kong over 5 consecutive years (2012-17). We included those who were admitted to general wards in four public hospitals in Hong Kong with a fever (≥38°C) and any respiratory symptom, such as runny nose, cough, or sore throat. We used direct immunofluorescence assay and reverse transcription PCR to detect influenza virus infection, and recorded children's influenza immunisation history. We compared characteristics of positive cases and negative controls and examined how vaccine effectiveness changed by time between vaccination and admission to hospital with regression analyses. FINDINGS: Between Sept 1, 2012, and Aug 31, 2017, we enrolled 15 695 children hospitalised for respiratory infections, including 2500 (15·9%) who tested positive for influenza A or B and 13 195 (84·1%) who tested negative. 159 (6·4%) influenza-positive cases and 1445 (11·0%) influenza-negative cases had been vaccinated. Most vaccinations were done by December of each influenza vaccination season. Influenza-related admissions to hospital occurred year-round, with peaks in January through March in most years and a large summer peak in 2016; pooled vaccine effectiveness for children of all ages was 79% (95% CI 42-92) for September to December, 67% (57-74) for January to April, and 43% (25-57) for May to August. Vaccine effectiveness against influenza A or B was estimated as 79% (95% CI 64-88) within 0·5-2 months of vaccination, 60% (46-71) within >2-4 months, 57% (39-70) within >4-6 months, and 45% (22-61) within >6-9 months. In separate analyses by type and subtype, we estimated that vaccine effectiveness declined by 2-5 percentage points per month. INTERPRETATION:Influenza vaccine effectiveness decreased during the 9 months after vaccination in children in Hong Kong. Our findings confirm the importance of annual vaccination in children. Influenza vaccines that provide broader and longer-lasting protection are needed to provide year-round protection in regions with irregular influenza seasonality or lengthy periods of influenza activity. FUNDING: Health and Medical Research Fund, Hong Kong and the Research Grants Council, Hong Kong.
Authors: Jui-fen R Lu; Gabriel M Leung; Soonman Kwon; Keith Y K Tin; Eddy Van Doorslaer; Owen O'Donnell Journal: Soc Sci Med Date: 2006-10-02 Impact factor: 4.634
Authors: Sophia Ng; Vicky J Fang; Dennis K M Ip; Kwok-Hung Chan; Gabriel M Leung; J S Malik Peiris; Benjamin J Cowling Journal: J Infect Dis Date: 2013-08-01 Impact factor: 5.226
Authors: R G Pebody; N Andrews; J McMenamin; H Durnall; J Ellis; C I Thompson; C Robertson; S Cottrell; B Smyth; M Zambon; C Moore; D M Fleming; J M Watson Journal: Euro Surveill Date: 2013-01-31
Authors: E Kissling; M Valenciano; A Larrauri; B Oroszi; J M Cohen; B Nunes; D Pitigoi; C Rizzo; J Rebolledo; I Paradowska-Stankiewicz; S Jiménez-Jorge; J K Horváth; I Daviaud; R Guiomar; G Necula; A Bella; J O'Donnell; M Głuchowska; B C Ciancio; A Nicoll; A Moren Journal: Euro Surveill Date: 2013-01-31
Authors: Mark Loeb; Margaret L Russell; Lorraine Moss; Kevin Fonseca; Julie Fox; David J D Earn; Fred Aoki; Gregory Horsman; Paul Van Caeseele; Khami Chokani; Mark Vooght; Lorne Babiuk; Richard Webby; Stephen D Walter Journal: JAMA Date: 2010-03-10 Impact factor: 56.272
Authors: Peng Wu; Edward Goldstein; Lai Ming Ho; Lin Yang; Hiroshi Nishiura; Joseph T Wu; Dennis K M Ip; Shuk-Kwan Chuang; Thomas Tsang; Benjamin J Cowling Journal: J Infect Dis Date: 2012-10-08 Impact factor: 5.226
Authors: J Castilla; I Martínez-Baz; V Martínez-Artola; G Reina; F Pozo; M García Cenoz; M Guevara; J Morán; F Irisarri; M Arriazu; E Albéniz; C Ezpeleta; A Barricarte Journal: Euro Surveill Date: 2013-01-31
Authors: Silvia Jiménez-Jorge; Salvador de Mateo; Concha Delgado-Sanz; Francisco Pozo; Inmaculada Casas; Manuel Garcia-Cenoz; Jesús Castilla; Esteban Pérez; Virtudes Gallardo; Carolina Rodriguez; Tomás Vega; Carmen Quiñones; Eva Martínez; Juana María Vanrell; Jaume Giménez; Daniel Castrillejo; María del Carmen Serrano; Julián Mauro Ramos; Amparo Larrauri Journal: BMC Infect Dis Date: 2013-09-22 Impact factor: 3.090
Authors: Huiying Chua; Susan S Chiu; Eunice L Y Chan; Shuo Feng; Mike Y W Kwan; Joshua S C Wong; J S Malik Peiris; Benjamin J Cowling Journal: J Infect Dis Date: 2019-10-08 Impact factor: 5.226
Authors: Mark W Tenforde; Wesley H Self; Eric A Naioti; Adit A Ginde; David J Douin; Samantha M Olson; H Keipp Talbot; Jonathan D Casey; Nicholas M Mohr; Anne Zepeski; Manjusha Gaglani; Tresa McNeal; Shekhar Ghamande; Nathan I Shapiro; Kevin W Gibbs; D Clark Files; David N Hager; Arber Shehu; Matthew E Prekker; Heidi L Erickson; Michelle N Gong; Amira Mohamed; Daniel J Henning; Jay S Steingrub; Ithan D Peltan; Samuel M Brown; Emily T Martin; Arnold S Monto; Akram Khan; Catherine L Hough; Laurence W Busse; Caitlin C Ten Lohuis; Abhijit Duggal; Jennifer G Wilson; Alexandra June Gordon; Nida Qadir; Steven Y Chang; Christopher Mallow; Carolina Rivas; Hilary M Babcock; Jennie H Kwon; Matthew C Exline; Natasha Halasa; James D Chappell; Adam S Lauring; Carlos G Grijalva; Todd W Rice; Ian D Jones; William B Stubblefield; Adrienne Baughman; Kelsey N Womack; Christopher J Lindsell; Kimberly W Hart; Yuwei Zhu; Meagan Stephenson; Stephanie J Schrag; Miwako Kobayashi; Jennifer R Verani; Manish M Patel Journal: MMWR Morb Mortal Wkly Rep Date: 2021-08-27 Impact factor: 35.301
Authors: Susan S Chiu; Mike Yw Kwan; Shuo Feng; Eunice Ly Chan; Huiying Chua; Joshua Sc Wong; Js Malik Peiris; Benjamin J Cowling Journal: Euro Surveill Date: 2019-01
Authors: Ian G Barr; Yi Mo Deng; Miguel L Grau; Alvin X Han; Robin Gilmour; Melissa Irwin; Peter Markey; Kevin Freeman; Geoff Higgins; Mark Turra; Naomi Komadina; Heidi Peck; Robert Booy; Sebastian Maurer-Stroh; Vijaykrishna Dhanasekaran; Sheena Sullivan Journal: Euro Surveill Date: 2019-08
Authors: Edward C Holmes; Aeron C Hurt; Zuzana Dobbie; Barry Clinch; John S Oxford; Pedro A Piedra Journal: Clin Microbiol Rev Date: 2021-02-10 Impact factor: 26.132
Authors: Tawee Chotpitayasunondh; Thea Kølsen Fischer; Jean-Michel Heraud; Aeron C Hurt; Arnold S Monto; Albert Osterhaus; Yuelong Shu; John S Tam Journal: Influenza Other Respir Viruses Date: 2020-10-31 Impact factor: 4.380